Table 1.
The number of programmed cell death (PCD) genes and enrichment analysis.
| No. of genes | No. of PCD genes | No. of type 1 PCD genes | No. of type 2 PCD genes | No. of type 3 PCD genes | |
|---|---|---|---|---|---|
| Cluster 1 | 342 | 0 | 0 | 0 | 0 |
| Cluster 2 | 536 | 13 | 5 | 7 | 6 |
| Cluster 3 | 69 | 1 | 0 | 0 | 1 |
| Cluster 4 | 158 | 0 | 0 | 0 | 0 |
| Cluster 5 | 151 | 6 | 6*** | 0 | 1 |
| Cluster 6 | 521 | 28**,*** | 19**,*** | 16**,*** | 8 |
| Cluster 7 | 399 | 29**,*** | 18**,*** | 18**,*** | 6 |
| Cluster 8 | 857 | 49**,*** | 36**,*** | 28**,*** | 10 |
| Cluster 9 | 38 | 4**,*** | 1 | 3**,*** | 0 |
| Clusters | 2,219 | 79* | 50* | 38* | 21 |
| Not in clusters | 4,597 | 124 | 64 | 43 | 37 |
| Network | 6,816 | 203* | 114* | 81* | 58* |
| Not in network | 50,472 | 113 | 28 | 50 | 41 |
| Pan-cancer-wide selected genes | 4,546 | 43* | 19* | 15 | 20* |
| Non-pan-cancer-wide selected genes | 52,742 | 273 | 123 | 116 | 79 |
*PCD genes were enriched in genes in clusters, networks, and PSGs compared to other genes not in clusters, networks, or PSGs.
**PCD genes were enriched compared to other genes in clusters.
***PCD genes were enriched compared to other genes in networks.